| 5WR7: reference: Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer., Tanaka H, Sase H, Tsukaguchi T, Hasegawa M, Tanimura H, Yoshida M, Sakata K, Fujii T, Tachibana Y, Takanashi K, Higashida A, Hasegawa K, Ono Y, Oikawa N, Mio T, Mol Cancer Ther. 2018 Dec;17(12):2519-2529. doi: 10.1158/1535-7163.MCT-17-1180., Epub 2018 Sep 21. PMID: 30242093 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).